Chengdu, China

Huiling Liu

This inventor holds 1 USPTO granted patent. Top assignee: Sichuan University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Huiling Liu. Retrieved from https://idiyas.com/inventor/huiling-liu-vm1fq9e1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Huiling Liu: Innovator in Developmental Dysplasia Treatment

Introduction

Huiling Liu is a prominent inventor based in Chengdu, China. She has made significant contributions to the field of medical treatments, particularly in addressing developmental dysplasia of the hip. Her innovative approach has garnered attention in the medical community.

Latest Patents

Huiling Liu holds a patent for "Methods for treating developmental dysplasia of the hip." This patent outlines a method that includes administering a therapeutically effective amount of a pharmaceutical composition to a subject suffering from this condition. The composition features a substance capable of inhibiting the expression of Midkine (MDK), specifically utilizing a Midkine inhibitor (IMDK).

Career Highlights

Huiling Liu is affiliated with Sichuan University, where she continues her research and development efforts. Her work has been instrumental in advancing treatment options for patients with developmental dysplasia of the hip. Liu's dedication to her field is evident through her innovative patent and ongoing research.

Collaborations

Huiling Liu collaborates with notable colleagues, including Weili Fu and Runze Yang. These partnerships enhance her research capabilities and contribute to the development of effective treatment methods.

Conclusion

Huiling Liu's contributions to the treatment of developmental dysplasia of the hip highlight her role as an innovative inventor in the medical field. Her patent and collaborative efforts reflect her commitment to improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…